Bing Yao

13PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 22, 2026
Stress granules restrain ferroptosis by sequestering ferritin.

|Apr 01, 2026
LDHA-driven lactate metabolism promotes MDSC activation and immunosuppressive microenvironment in prostate cancer.

Xiyi Wei, Xiao Li, Yitong Pan

|Mar 30, 2026
Reinvigorating COTL1high NK cells via GITR signalling overcomes immune checkpoint blockade resistance in tsMHC-I-impaired tumours.

Wenhua You, Chupeng Hu, Yuhan Zhang

|Jan 21, 2026
Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy.

Lili Niu, Wei Su, Lixia Ju

|Dec 06, 2025
OPRK1 drives SLC9A3R1 progression to neuroendocrine prostate cancer.

Linghui Liang, Zhiyi Shen, Yuwei Zhang

|May 30, 2025
PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer.

Shuang Qu, Baijie Feng, Mengying Xing

Pageof 3

Frequent Collaborators

3 joint publications

Zhou Yang

2 joint publications

Changyan Ma

2 joint publications

Shouyong Gu

1 joint publications

Xiao-Fang Yu